Notice of General Meeting/ Proxy Form
ASX Announcement General iTrack Molteno3 AlphaRET
14 Feb, 2025
Change in substantial shareholding from AEF
ASX Announcement General iTrack Molteno3 AlphaRET
11 Feb, 2025
Cleansing Notice
ASX Announcement General iTrack Molteno3 AlphaRET
7 Feb, 2025
Appendix 2A - Application for quotation of Securities
ASX Announcement General iTrack Molteno3 AlphaRET
7 Feb, 2025
Investor Presentation January 2025
ASX Announcement General iTrack Molteno3 AlphaRET
31 Jan, 2025
December 2024 Quarterly Activities Report, Appendix 4C and Revenue Guidance
ASX Announcement General iTrack Molteno3 AlphaRET
31 Jan, 2025
Nova Eye Completes $6.6 Million Capital Raising
ASX Announcement General iTrack Molteno3 AlphaRET
31 Jan, 2025
Appendix 3B - Proposed issue of securities
ASX Announcement General iTrack Molteno3 AlphaRET
31 Jan, 2025
Trading Halt
ASX Announcement General iTrack Molteno3 AlphaRET
29 Jan, 2025
2024 AGM Presentation
ASX Announcement General iTrack Molteno3 AlphaRET
21 Nov, 2024
September 2024 Quarterly Activities Report and Appendix 4C
ASX Announcement General iTrack Molteno3 AlphaRET
31 Oct, 2024
Notice of Annual General Meeting 2024
ASX Announcement General iTrack Molteno3 AlphaRET
18 Oct, 2024
Date of AGM and Closing Date for Director Nominations
ASX Announcement General iTrack Molteno3 AlphaRET
27 Sept, 2024
FY2024 Results Presentation
ASX Announcement General iTrack Molteno3 AlphaRET
26 Aug, 2024
FY2024 ASX Results Announcement
ASX Announcement General iTrack Molteno3 AlphaRET
26 Aug, 2024
FY2024 Appendix 4E and Annual Report
ASX Announcement General iTrack Molteno3 AlphaRET
26 Aug, 2024
FY2024 Appendix 4G and Governance Statement
ASX Announcement General iTrack Molteno3 AlphaRET
26 Aug, 2024
Presentation on FY24 Sales
ASX Announcement General iTrack Molteno3 AlphaRET
8 July, 2024
Record Sales Result in FY24
ASX Announcement General iTrack Molteno3 AlphaRET
8 July, 2024
USA Medicare Reimbursement Update
ASX Announcement iTrack
31 May, 2024
Ceasing to be a substantial holder
ASX Announcement General iTrack Molteno3 AlphaRET
20 Mar, 2024
Change in substantial shareholding from AEF
ASX Announcement General iTrack Molteno3 AlphaRET
20 Mar, 2024
Change of Director's Interest Notice VP
ASX Announcement General iTrack Molteno3 AlphaRET
19 Mar, 2024
Change of Director's Interest Notice VP
ASX Announcement General iTrack Molteno3 AlphaRET
19 Mar, 2024
Change of Director's Interest Notice
ASX Announcement General iTrack Molteno3 AlphaRET
19 Mar, 2024
Retail Entitlement Offer Complete
ASX Announcement General iTrack Molteno3 AlphaRET
15 Mar, 2024
Record USA Sales for February 2024
ASX Announcement General iTrack Molteno3 AlphaRET
5 Mar, 2024
Half Yearly Report and Accounts
ASX Announcement General iTrack Molteno3 AlphaRET
23 Feb, 2024
Cleansing Notice
ASX Announcement General iTrack Molteno3 AlphaRET
23 Feb, 2024
Despatch of Entitlement offer Completed
ASX Announcement General iTrack Molteno3 AlphaRET
19 Feb, 2024
Retail Entitlement Offer Booklet
ASX Announcement General iTrack Molteno3 AlphaRET
19 Feb, 2024
Appendix 3B - Proposed Issue of Securities
ASX Announcement General iTrack Molteno3 AlphaRET
14 Feb, 2024
EYE Placement & Institutional Offer Completion
ASX Announcement General iTrack Molteno3 AlphaRET
14 Feb, 2024
Investor Presentation
ASX Announcement General iTrack Molteno3 AlphaRET
12 Feb, 2024
Proposed issue of securities
ASX Announcement General iTrack Molteno3 AlphaRET
12 Feb, 2024
Cleansing Notice - Notice under section 708AA(2)(f) of the Corporations Act 2001 (Cth)
ASX Announcement General iTrack Molteno3 AlphaRET
12 Feb, 2024
Capital Raise for Expansion
ASX Announcement General iTrack Molteno3 AlphaRET
12 Feb, 2024
Trading Halt
ASX Announcement General iTrack Molteno3 AlphaRET
12 Feb, 2024
USA Sales Update
ASX Announcement iTrack
8 Jan, 2024
Response to ASX Aware Query
ASX Announcement General iTrack Molteno3 AlphaRET
4 Jan, 2024
USA Medicare Changes Withdrawn
ASX Announcement General iTrack Molteno3 AlphaRET
29 Dec, 2023
Deferral of Proposed USA Medicare Changes
ASX Announcement General iTrack Molteno3 AlphaRET
8 Dec, 2023
Further Update of Proposed USA Medicare Changes
ASX Announcement General iTrack Molteno3 AlphaRET
28 Nov, 2023
AGM Presentation
ASX Announcement General iTrack Molteno3 AlphaRET
23 Nov, 2023
Further Update on Proposed USA Medicare Changes
ASX Announcement General iTrack Molteno3 AlphaRET
14 Nov, 2023
Trading Halt
ASX Announcement General iTrack Molteno3 AlphaRET
10 Nov, 2023
Proposed USA Medicare Changes
ASX Announcement General iTrack Molteno3 AlphaRET
31 Oct, 2023
Trading Halt
ASX Announcement General iTrack Molteno3 AlphaRET
27 Oct, 2023
Preliminary Clinical Results Shows Potential For Addressable Market
ASX Announcement iTrack
25 Oct, 2023
Notice of Annual General Meeting
ASX Announcement General iTrack Molteno3 AlphaRET
20 Oct, 2023
Date of AGM & Closing Date for Director Nominations
ASX Announcement General iTrack Molteno3 AlphaRET
25 Sept, 2023
INVESTOR WEBINAR PRESENTATION - SHARECAFE
ASX Announcement General iTrack Molteno3 AlphaRET
15 Sept, 2023
Evans & Partners Small Cap Healthcare Conference Presentation
ASX Announcement General iTrack Molteno3 AlphaRET
12 Sept, 2023
EYE FY2023 Appendix 4G and Governance Statement
ASX Announcement General iTrack Molteno3 AlphaRET
28 Aug, 2023
EYE FY2023 Results Announcement
ASX Announcement General iTrack Molteno3 AlphaRET
28 Aug, 2023
EYE FY2023 Results Presentation
ASX Announcement General iTrack Molteno3 AlphaRET
28 Aug, 2023
EYE FY2023 Appendix 4E and Annual Report
ASX Announcement General iTrack Molteno3 AlphaRET
28 Aug, 2023
Investor Webinar Full Year (FY23) Results
ASX Announcement General iTrack Molteno3 AlphaRET
23 Aug, 2023
TechKnow Invest Roadshow Presentation August 2023
ASX Announcement General iTrack Molteno3 AlphaRET
3 Aug, 2023
iTrack™ Advance Sales in the USA Driving Strong Results
ASX Announcement General iTrack Molteno3 AlphaRET
2 Aug, 2023
Investor Presentation - ShareCafe
ASX Announcement General iTrack Molteno3 AlphaRET
19 May, 2023
Cleansing Notice
ASX Announcement General iTrack Molteno3 AlphaRET
5 May, 2023
Application for Quotation of Securities
ASX Announcement General iTrack Molteno3 AlphaRET
5 May, 2023
iTrack Advance First Surgeries and Sales in USA
ASX Announcement General iTrack Molteno3 AlphaRET
1 May, 2023
FDA Clears iTrack Advance for US Launch
ASX Announcement General iTrack Molteno3 AlphaRET
31 Mar, 2023
Notice of General Meeting
ASX Announcement General iTrack Molteno3 AlphaRET
28 Mar, 2023
Application for Quotation of Securities
ASX Announcement General iTrack Molteno3 AlphaRET
8 Mar, 2023
Cleansing Notice
ASX Announcement General iTrack Molteno3 AlphaRET
8 Mar, 2023
Reinstatement to Quotation
ASX Announcement General iTrack Molteno3 AlphaRET
2 Mar, 2023
Proposed issue of securities - 2 March 2023
ASX Announcement General iTrack Molteno3 AlphaRET
2 Mar, 2023
Half Yearly Accounts 31 December 2022
ASX Announcement General iTrack Molteno3 AlphaRET
2 Mar, 2023
Investor Presentation Half Year Results 31 Dec 2022
ASX Announcement General iTrack Molteno3 AlphaRET
2 Mar, 2023
Nova Eye Completes $8m Placement
ASX Announcement General iTrack Molteno3 AlphaRET
2 Mar, 2023
Suspension from Official Quotation
ASX Announcement General iTrack Molteno3 AlphaRET
28 Feb, 2023
Trading Halt
ASX Announcement General iTrack Molteno3 AlphaRET
27 Feb, 2023
For investor enquires please contact:
Mark Flynn
Nova Eye Medical Limited
W +61 416 068 733
mflynn@nova-eye.com